INT'L GROUP(SZ:000411)2025-11-05 07:50Group 1: Company Overview - The main business of the company includes wholesale and retail of pharmaceuticals, traditional Chinese medicine, biological products, and medical devices [2] - The operational model involves purchasing products from upstream pharmaceutical manufacturers and supplying them to downstream medical institutions, pharmacies, and distributors, as well as direct sales to consumers [2] Group 2: Acquisition of Huadong Pharmaceutical - The acquisition of Huadong Pharmaceutical has been completed, making it a wholly-owned subsidiary of the company [2] - Huadong Pharmaceutical has a strong presence in the grassroots public medical market and its retail segment ranks among the top in the pharmaceutical retail industry, which aligns well with the company's existing operations [2] - This acquisition is expected to enhance the company's market share in Zhejiang, improve negotiation power with suppliers, and increase influence over end consumers, contributing to high-quality development [2] Group 3: Accounts Receivable Management - The company reports a stable accounts receivable collection cycle, with variations across different regions in Zhejiang and among different customer types [2] - A comprehensive credit risk management system has been established to oversee accounts receivable turnover [2] Group 4: Shitang Pharmaceutical Industrial Park - The company’s wholly-owned subsidiary, Zhejiang Yinte Smart Network Technology Co., Ltd., acquired land for the Shitang Pharmaceutical Industrial Park project, covering an area of 79,357 square meters [3] - The project is aimed at enhancing the company's operational capabilities in the pharmaceutical sector [3]